GeneCentrix, Inc.
Biotechnology ResearchNew York, United States2-10 Employees
GeneCentrix, Inc. is a biotechnology research company based in New York City, focusing on bioinformatics to support early-stage drug discovery. Its work centers on linking drugs to disease-associated phenotypes by mapping the proteins a compound binds to with the tissues where those proteins are expressed, creating a target-tissue–based profile that can be used to identify potential drug targets and candidates. The company emphasizes leveraging large-scale data resources to develop algorithms that connect diseases and phenotypes with existing and novel therapeutics, aiming to streamline the drug development process. Its signature offering, the Historeceptomics Profiler, integrates chemical search with gene target information to provide insights on potential adverse effects and alternative uses for drugs, supporting researchers in evaluating drug action beyond conventional methods. GeneCentrix presents itself as a niche player in the biotechnology research sector, pursuing in silico methods to accelerate target identification and drug repurposing for complex diseases. A recent development noted is a 21-day free trial for its platform, indicating ongoing access to its profiling service.
1-888-653-2347 
support@leadiq.com 
